Icon plc

ICON acquires HumanFirst, a cloud-based technology company for life sciences supporting precision measurement in patient centred clinical research.

Powered by. It provides specialized services that span the entire lifecycle of product development. Bolster business development with timely opportunities. Review investigator profiles and find information on trial contacts across ICON Plc, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics. Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Icon plc

ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. Lambe retired from the board of directors in Contents move to sidebar hide. Article Talk. Read Edit View history. Tools Tools. Download as PDF Printable version. See also: Icon disambiguation. Irish pharmaceutical company. Traded as. Contract research organization Pharmaceutical Medical device Life sciences Consulting.

In September, the company entered into a partnership with the U.

.

CEO Dr. Our world class team aided in the development of 30 customer drug and device approvals in the year, including breakthrough COVID vaccines and therapies. Additionally, a number of discussions have continued with customers contemplating an expanded or new strategic relationship with ICON, as the increased scale, innovative solutions and best in class performance of new ICON address unmet industry needs. This represents a year on year increase of In addition to the financial measures prepared in accordance with generally accepted accounting principles GAAP , this press release contains certain non-GAAP financial measures, including adjusted revenue, adjusted EBITDA, adjusted net income attributable to the Group and adjusted diluted earnings per share attributable to the Group. To assist investors and analysts with year-over-year comparability for the merged business, we have included Combined Company information. Specifically, these financials represent the simple addition of the historical adjusted financials of each company. These combined financials are not intended to represent pro forma financial statements prepared in accordance with GAAP or Regulation S-X.

Icon plc

ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. Lambe retired from the board of directors in Contents move to sidebar hide. Article Talk.

Surprise birthday spinner google

ICON plc. Market Access Expertise in mission-critical pricing, market access, and reimbursement. Retrieved 19 February No of Employees 41, Contract Pharma. Key Financial Charts. Dismiss Search Modal. Hidden categories: Articles with short description Short description matches Wikidata Articles containing potentially dated statements from June All articles containing potentially dated statements. December Chief Information Officer. Health Economics. Contract research organization Pharmaceutical Medical device Life sciences Consulting. Net Income XYZ Headquarters Ireland.

The new ICON will have a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development. ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations.

Steve Cutler , CEO. Navigating the regulatory labyrinth of technology in decentralised clinical trials Keeping up to date and implementing the latest guidelines. Retrieved 19 February Tools Tools. Red Robin Gourmet Burgers, Inc. Sign in. Crosstree Capital. October A multifaceted risk factor: Addressing obesity's impact across the disease spectrum Read the whitepaper. Securities and Exchange Commission.